| Website | gemmuspharma.com |
| Category | BioTech |
| Phone | 415-978-2151 |
| incoming@gemmusph... | |
| Employees | |
| Founded | 2007 |
| Description | A drug development company |
| VENTURE FUNDING | |
| Series A, 6/12 Life Science Angels BlueTree Allied Angels Tech Coast Angels Wilmington Investor Network The Angels' Forum |
Gemmus Pharma is a drug development company founded in 2007 to commercialize in-licensed technology from a major pharmaceutical company. Gemmus’ lead candidate is a cardiovascular drug currently marketed in Asia that has been repurposed for use as a treatment for influenza. Gemmus has received support from the National Institute of Allergy and Infectious Disease (NIAID) and has completed a Series A round. Gemmus plans to file an investigational new drug (IND) application with the FDA for treatment of influenza infections in 2014.
